[NKTR] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[NKTR] Nektar Therapeutics
Announcement Date
27-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -164.68%
Quarter Report
NKTR's Result
NKTR's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 92,055 101,907 152,915 114,617 1,193,323 307,711 165,436 -9.30%
PBT -364,983 -523,280 -443,947 -440,054 682,725 -96,076 -152,648 15.62%
Tax 3,215 557 493 613 1,412 616 876 24.18%
NP -368,198 -523,837 -444,440 -440,667 681,313 -96,692 -153,524 15.68%
Tax Rate - - - - -0.21% - - -
Total Cost 460,253 625,744 597,355 555,284 512,010 404,403 318,960 6.29%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -399.98 -514.03 -290.65 -384.47 57.09 -31.42 -92.80 27.55%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -1.97 -2.86 -2.49 -2.52 3.78 -0.62 -1.10 10.19%
EPS Diluted -1.97 -2.86 -2.49 -2.52 3.78 -0.62 -1.10 10.19%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.